Microbot Medical Inc/ US59503A2042 /
| 9/10/2024 9:55:48 PM | Chg. -0.0039 | Volume | Bid10:00:00 PM | Ask10:00:00 PM | High | Low |
|---|---|---|---|---|---|---|
| 0.9010USD | -0.43% | 36,553 Turnover: 28,821.8556 |
0.8933Bid Size: 100 | 0.9320Ask Size: 100 | 0.9193 | 0.8900 |
GlobeNewswire
8/22
Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesu...
GlobeNewswire
8/13
Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commerc...
GlobeNewswire
8/1
Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY®...
GlobeNewswire
7/18
Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with...
GlobeNewswire
7/9
Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial
GlobeNewswire
7/3
Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinica...
GlobeNewswire
6/20
Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
GlobeNewswire
6/17
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Tri...
GlobeNewswire
6/4
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market ...
GlobeNewswire
6/3
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasda...
GlobeNewswire
6/3
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
GlobeNewswire
4/29
Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell ...
GlobeNewswire
2/5
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Tr...
GlobeNewswire
1/30
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Le...
GlobeNewswire
1/18
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Com...
GlobeNewswire
12/29/2023
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in...
GlobeNewswire
12/28/2023
Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Ob...
GlobeNewswire
12/14/2023
Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robo...
GlobeNewswire
12/7/2023
Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critic...
GlobeNewswire
11/21/2023
Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical O...
GlobeNewswire
11/13/2023
Microbot Medical Successfully Completed Integral Part of the Verification and Validation Process
GlobeNewswire
11/8/2023
Microbot Medical Granted Registered Trademark from The U.S. Patent and Trademark Office
